Type 2 Diabetes
Excellence Forum
Leaders in the field share expert insights and institutional best practices.
Featured
06/18/2024
In a recent retrospective cohort study, researchers examined changes in the medication regimens of patients with type 2 diabetes following the initiation of second-line therapy.
06/18/2024
06/17/2024
Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about how clinicians can individualize care for their patients with type 2 diabetes, including strategies that can be used, what...
06/17/2024
06/11/2024
Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Interactive Features
10/28/2023
Your patient is a 12-year-old girl who is overweight. Obesity runs in her family’s history and her father has type 2 diabetes. Her parents believe she should be screened for diabetes.
10/28/2023
07/10/2023
Your patient is a 55-year-old man with type 2 diabetes who is worried about his health as he ages. He asks you if there are any recommended forms of exercise that can help him feel better about his health....
07/10/2023
06/26/2015
There are “myths” that surround the use of GLP-1 receptor agonists among patients, and it is a health care provider’s role to help their patients understand the benefits and adverse effects of these...
06/26/2015
Clinical Insights
06/17/2024
Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about how clinicians can individualize care for their patients with type 2 diabetes, including strategies that can be used, what...
06/17/2024
06/11/2024
Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Video: Multidisciplinary Roundtable
Video: Multidisciplinary Roundtable
02/05/2024
In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with...
02/05/2024
01/14/2024
In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma,...
01/14/2024
